Skip to main content

TC BioPharm (Holdings) plc

TCBPDelisted Aug 8, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001872812

TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by TC BioPharm (Holdings) plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for TC BioPharm (Holdings) plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for TC BioPharm (Holdings) plc
NameTitleLast reported holdingLast filingFilings, past year
Randall Mark Edward10% Owner136,834IndirectJan 11, 20230
Randall Diana Elizabeth10% Owner70,000IndirectJan 11, 20230
Renaissance Capital Partners Ltd10% Owner136,834Jan 11, 20230
Randall Kenneth Edward10% Owner136,834IndirectJan 11, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 11, 2023 (view filing)Nov 30, 202242 daysLateRandall Diana Elizabeth10% OwnerPPurchaseOrdinary Shares [ADS]+70.0K$5.00+$350.0KNew position70.0K after
Jan 11, 2023 (view filing)Nov 30, 202242 daysLateRandall Diana Elizabeth10% OwnerPPurchase+140.0K$0.00$0–70.0K afterDerivative2 lotsDuplicate filing
Jan 11, 2023 (view filing)Nov 30, 202242 daysRandall Mark Edward10% OwnerPPurchaseOrdinary Shares [ADS]+70.0K$5.00+$350.0K+104.7%136.8K afterAmendedDuplicate filing
Jan 11, 2023 (view filing)Nov 30, 202242 daysRandall Mark Edward10% OwnerPPurchase+140.0K$0.00$0–70.0K afterAmendedDerivative2 lotsDuplicate filing
Jan 11, 2023 (view filing)Nov 30, 202242 daysRandall Kenneth Edward10% OwnerPPurchaseOrdinary Shares [ADS]+70.0K$5.00+$350.0K+104.7%136.8K afterAmendedDuplicate filing
Jan 11, 2023 (view filing)Nov 30, 202242 daysRandall Kenneth Edward10% OwnerPPurchase+140.0K$0.00$0–70.0K afterAmendedDerivative2 lotsDuplicate filing
Jan 11, 2023 (view filing)Nov 30, 202242 daysLateRenaissance Capital Partners Ltd10% OwnerPPurchaseOrdinary Shares [ADS]+70.0K$5.00+$350.0K+104.7%136.8K after
Jan 11, 2023 (view filing)Nov 30, 202242 daysLateRenaissance Capital Partners Ltd10% OwnerPPurchase+140.0K$0.00$0–70.0K afterDerivative2 lots
Jul 14, 2022 (view filing)May 2451 daysLateRandall Kenneth Edward10% OwnerPPurchaseOrdinary Shares [ADS]+20.8K$1.15+$23.9K+26.1%100.4K after